Company Update: Allergan Inc (NYSE:AGN) – Allergan Announces Agreement with Amneal Related to NAMENDA XR® Patent Litigation

[PR Newswire] – DUBLIN, Sept. 10, 2015 /PRNewswire/ — Allergan plc (AGN), today announced that its subsidiaries Forest Laboratories, LLC and Forest Laboratories Holdings, Ltd., along with Adamas Pharmaceuticals, Inc., have entered into . . . → Read More: Company Update: Allergan Inc (NYSE:AGN) – Allergan Announces Agreement with Amneal Related to NAMENDA XR® Patent Litigation Similar Articles: Company Update (NYSE:AGN): Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan’s Pending Acquisition of KYTHERA Market Update (NYSE:AGN): Allergan Notes Receipt of Paragraph IV Notification on Restasis Stock Update: Raytheon Co (NYSE:RTN) – Raytheon and Vista Equity Partners enter agreement to form new cybersecurity company